Welcome to our dedicated page for Claritev news (Ticker: CTEV), a resource for investors and traders seeking the latest updates and insights on Claritev stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Claritev's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Claritev's position in the market.
Claritev (NYSE:CTEV) announced that its PHCS Network has received its 12th consecutive NCQA Accreditation in Credentialing. The PHCS Network, the largest primary PPO in the nation, is the only national independently contracted primary PPO with NCQA accreditation.
The accreditation is valid through June 13, 2028, following a rigorous review of credentialing processes. The PHCS Network serves nationwide with over 1 million participating practitioners, 4,600 acute care facilities, and 92,000 ancillaries.
Claritev (NYSE: CTEV) is strengthening its presence in the Middle East North Africa (MENA) region through key strategic moves. The company has appointed Mohamed Ramzy as Senior Vice President and General Manager, International, who will report directly to CEO Travis Dalton and oversee MENA operations. Ramzy brings nearly 20 years of healthcare technology experience, previously serving as Country General Manager at Oracle Health.
Additionally, Claritev has established a strategic partnership with Halian, a global workforce and technology solutions provider, to manage its UAE operations including payroll, recruitment, and human capital administration. These initiatives follow Claritev's previous collaborations with Burjeel Holdings and Claims Care Revenue Cycle Management, reinforcing the company's commitment to expanding its international footprint and delivering localized healthcare technology solutions.
Claritev (NYSE: CTEV) and Claims Care Revenue Cycle Management, a division of Burjeel Holdings (ADX: BURJEEL), have formalized their strategic partnership to transform revenue cycle management in the MENA region. The collaboration combines Claritev's advanced claims analytics and AI-driven solutions with Claims Care's regional expertise.
Key partnership highlights include: accelerated product development for MENA-tailored RCM solutions, operational synergies through transitioning Claritev's offshore processes to Claims Care, enhanced healthcare delivery efficiency, and strategic market expansion. Claritev anticipates generating regional revenues during 2025.
Claritev (NYSE: CTEV) has announced a strategic partnership with Lantern to enhance healthcare cost transparency and optimization. The collaboration integrates Claritev's BenInsights® and HST Connect® solutions with Lantern's Network of Excellence and TrueRate™ methodology. The partnership will focus on two key areas: Enhanced Data Analytics through BenInsights, providing comprehensive healthcare spending visibility, and Optimized Patient Steering via HST Connect, guiding patients to cost-effective, high-quality providers.
The partnership builds on previous joint research and aims to address surgical costs, which represent 20% of employer health spending. Through this collaboration, both companies aim to deliver meaningful savings for employer groups while improving patient care quality through data-driven surgical cost analysis.
Claritev Corporation (NYSE: CTEV) has appointed Jason Kap to its Board of Directors, effective immediately following his election at the Company's Annual Meeting on April 30, 2025. Kap brings over 20 years of leadership experience in technology, pricing, and product transformation strategies. He currently serves as CEO of Blue Rocket Incorporated and previously held leadership positions at Microsoft Corporation and Zipwire, Inc. The appointment aligns with Claritev's technology-driven transformation strategy in healthcare cost optimization and revenue integrity solutions.
As a visiting scholar at MIT (2013-2020) and with extensive board experience, Kap's expertise will support Claritev's mission to make healthcare more affordable, transparent, and fair through technology, data, and insights.
Claritev (NYSE: CTEV) and Claims Care Revenue Cycle Management, a Burjeel Holdings division, have signed a memorandum of understanding (MOU) to expand revenue cycle management solutions in the Middle East and North Africa region. The partnership aims to:
- Leverage Claritev's Payment and Revenue Integrity solutions for the MENA payer market
- Create a joint product roadmap for advanced revenue cycle management capabilities
- Combine Claritev's Advanced Code Editing and Decision Science with Claims Care's regional expertise
- Transition certain offshore business processes to Claims Care
The collaboration brings together US and MENA market leaders to promote affordable, transparent, and higher quality healthcare services, marking a significant step in Claritev's global expansion strategy.
Claritev (NYSE: CTEV) has announced two key appointments to strengthen its leadership team as part of its business transformation strategy. Dr. Jigar S. Patel will join as Chief Medical Officer effective April 14, 2025, bringing over 18 years of experience from Cerner/Oracle. He will provide medical guidance on strategic development and product innovation of Claritev's healthcare technology solutions.
Dr. Fernando Schwartz has been appointed as Chief Artificial Intelligence Officer, effective February 17, 2025. With 15 years of leadership in data science and machine learning, Schwartz previously served as VP of AI at ADP and led global data science strategy at Merck's Human Health Division. He will lead the company's AI and analytics strategy under Chief Digital Officer Michael Kim.
Claritev (NYSE: CTEV) announced that its data solution Ceres® has won the 'Data Solution of the Year for Insurance' award in the 6th annual Data Breakthrough Awards' Industry Applications Category. Ceres is designed to help supplemental carriers and benefits brokers provide unbiased benefit recommendations.
The platform leverages AI-powered insights and de-identified claims data from over a million members to transform supplemental plan design from an intuition-based process into a data-driven approach. The solution enables modeling of different census scenarios to determine which benefits provide the highest value through predicted utilization and payout amounts, benchmarked against similar employer groups.
According to Travis Dalton, Chairman, CEO and President of Claritev, Ceres exemplifies their philosophy that data and technology should empower rather than replace people. The platform aims to shift focus from lowest-cost offerings to high-value, population-specific plans.
FAQ
What is the current stock price of Claritev (CTEV)?
What is the market cap of Claritev (CTEV)?
